ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment

ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment

A key tool for monitoring breast cancer patients under neoadjuvant treatment is the identification of reliable predictive markers. Ki67 has been identified as a prognostic and predictive marker in ER-positive breast cancer. Ninety ER-positive, HER2 negative locally advanced breast cancer patients re...

Full description

Bibliographic Details
Main Authors: A Ianza, F Giudici, C Pinello, SP Corona, C Strina, O Bernocchi, M Bortul, M Milani, M Sirico, G Allevi, S Aguggini, A Cocconi, C Azzini, M Dester, V Cervoni, A Bottini, M Cappelletti, D Generali
Format: Article
Language:English
Published: IOS Press 2020-06-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428320925301

Internet

https://doi.org/10.1177/1010428320925301

Similar Items